tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

JNJ Stock Latest News

Vaccine committee considers changes to childhood schedule, NY Times reports
The FlyVaccine committee considers changes to childhood schedule, NY Times reports
4h ago
AZN
BMY
Johnson & Johnson price target raised to $197 from $176 at Barclays
PremiumThe Fly
Johnson & Johnson price target raised to $197 from $176 at Barclays
5h ago
JNJ
Midday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK
PremiumThe Fly
Midday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK
22h ago
B
BX
Trump Trade: U.S. confirms agreement with U.K. on pharmaceutical pricing
PremiumThe Fly
Trump Trade: U.S. confirms agreement with U.K. on pharmaceutical pricing
1d ago
AZN
BMY
Is AstraZeneca’s Stock (AZN) a Good Investment Right Now?
PremiumMarket News
Is AstraZeneca’s Stock (AZN) a Good Investment Right Now?
1d ago
AZN
BMY
US government confirms agreement in principle with UK on pharmaceutical pricing
PremiumThe FlyUS government confirms agreement in principle with UK on pharmaceutical pricing
1d ago
AZN
BMY
US, UK expected to agree on zero-tariffs pharmaecuticals deal, UK Times says
Premium
The Fly
US, UK expected to agree on zero-tariffs pharmaecuticals deal, UK Times says
1d ago
AZN
BMY
The Week That Was, The Week Ahead: Macro & Markets, November 23, 2025
Premium
Market News
The Week That Was, The Week Ahead: Macro & Markets, November 23, 2025
9d ago
O
BE
Unusually active option classes on open November 21st
PremiumThe Fly
Unusually active option classes on open November 21st
11d ago
JNJ
ASPI
Unusually active option classes on open November 20th
PremiumThe Fly
Unusually active option classes on open November 20th
12d ago
COF
EWY
FDA grants traditional approval to J&J’s Darzalex Faspro for amyloidosis
PremiumThe Fly
FDA grants traditional approval to J&J’s Darzalex Faspro for amyloidosis
13d ago
JNJ
Zymeworks announces strategic initiative to optimize Ziihera cash flows
PremiumThe Fly
Zymeworks announces strategic initiative to optimize Ziihera cash flows
14d ago
JNJ
ZYME
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up: Monday’s Biggest Stock Market Stories!
15d ago
HD
KO
Midday Fly By: Berkshire takes Alphabet stake, J&J buying cancer drug maker
Premium
The Fly
Midday Fly By: Berkshire takes Alphabet stake, J&J buying cancer drug maker
15d ago
BA
EYE
M&A News: Johnson & Johnson Stock (JNJ) Perks Up as it Lands $3B “Hold and Kill” Cancer Deal
Premium
Market News
M&A News: Johnson & Johnson Stock (JNJ) Perks Up as it Lands $3B “Hold and Kill” Cancer Deal
15d ago
JNJ
Johnson & Johnson to acquire Halda Therapeutics for $3.05B in cash
PremiumThe Fly
Johnson & Johnson to acquire Halda Therapeutics for $3.05B in cash
15d ago
JNJ
Johnson & Johnson to acquire Halda Therapeutics for $3.05B, sees dilution
PremiumThe Fly
Johnson & Johnson to acquire Halda Therapeutics for $3.05B, sees dilution
15d ago
JNJ
Johnson & Johnson’s Tremfya shows positive results in psoriatic arthritis
PremiumThe Fly
Johnson & Johnson’s Tremfya shows positive results in psoriatic arthritis
15d ago
JNJ
Johnson & Johnson to acquire Halda Therapeutics for $3.05B in cash
PremiumThe Fly
Johnson & Johnson to acquire Halda Therapeutics for $3.05B in cash
15d ago
JNJ
Bristol Myers to stop Phase 3 Librexia ACS trial of milvexian
PremiumThe FlyBristol Myers to stop Phase 3 Librexia ACS trial of milvexian
18d ago
BMY
JNJ
Nike upgraded, Dollar Tree downgraded: Wall Street’s top analyst calls
Premium
The Fly
Nike upgraded, Dollar Tree downgraded: Wall Street’s top analyst calls
19d ago
AZO
BMY
Scotiabank starts 10 large cap drugmakers with ‘out-of-consensus’ positive view
Premium
The Fly
Scotiabank starts 10 large cap drugmakers with ‘out-of-consensus’ positive view
19d ago
BMY
JNJ

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >